These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15853711)

  • 21. Veterinary nuclear medicine.
    Krzemiński M; Lass P; Teodorczyk J; Krajka J
    Nucl Med Rev Cent East Eur; 2004; 7(2):177-82. PubMed ID: 15968607
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo imaging of gene expression.
    Sullivan DC; Hoffman JM
    Semin Radiat Oncol; 2001 Jan; 11(1):37-46. PubMed ID: 11146041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
    Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM
    Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiopharmaceuticals to monitor gene transfer.
    Wiebe LI; Morin KW; Knaus EE
    Q J Nucl Med; 1997 Jun; 41(2):79-89. PubMed ID: 9203847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aptamers as radiopharmaceuticals for nuclear imaging and therapy.
    Gijs M; Aerts A; Impens N; Baatout S; Luxen A
    Nucl Med Biol; 2016 Apr; 43(4):253-71. PubMed ID: 26746572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paediatric nuclear medicine imaging.
    Biassoni L; Easty M
    Br Med Bull; 2017 Sep; 123(1):127-148. PubMed ID: 28910997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P; Shen B; Zhao C; Tian G
    J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging gene expression: principles and assays.
    Gambhir SS; Barrio JR; Herschman HR; Phelps ME
    J Nucl Cardiol; 1999; 6(2):219-33. PubMed ID: 10327107
    [No Abstract]   [Full Text] [Related]  

  • 29. Veterinary Nuclear Medicine again--commentary and remarks on: Krzemiński M et al. Veterinary nuclear medicine--a review. NMR 2004; 7: 177-182.
    Balogh L; Máthé D; Andócs G; Polyák A; Király R; Thuróczy J; Szilágyi J; Chaudhari P; Janoki GA
    Nucl Med Rev Cent East Eur; 2005; 8(1):50-2. PubMed ID: 15977150
    [No Abstract]   [Full Text] [Related]  

  • 30. [Radionuclide reporter gene imaging].
    Zhang ZW; Zhang XM; Wu H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):728-30. PubMed ID: 14714323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.
    Mohan RR; Schultz GS; Hong JW; Mohan RR; Wilson SE
    Exp Eye Res; 2003 Mar; 76(3):373-83. PubMed ID: 12573666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
    Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
    J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense oligonucleotides and other genetic therapies made simple.
    Rossor AM; Reilly MM; Sleigh JN
    Pract Neurol; 2018 Apr; 18(2):126-131. PubMed ID: 29455156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular-genetic imaging: a nuclear medicine-based perspective.
    Blasberg RG; Gelovani J
    Mol Imaging; 2002 Jul; 1(3):280-300. PubMed ID: 12920854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide-mediated delivery of therapeutic and imaging agents into mammalian cells.
    Stefanidakis M; Koivunen E
    Curr Pharm Des; 2004; 10(24):3033-44. PubMed ID: 15379666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
    Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy.
    Panyutin IG; Winters TA; Feinendegen LE; Neumann RD
    Q J Nucl Med; 2000 Sep; 44(3):256-67. PubMed ID: 11105589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter.
    Niu G; Gaut AW; Ponto LL; Hichwa RD; Madsen MT; Graham MM; Domann FE
    J Nucl Med; 2004 Mar; 45(3):445-9. PubMed ID: 15001685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.
    Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD
    Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Target Selection for Nuclear Medicine Studies.
    Lee ST; Burvenich I; Scott AM
    Semin Nucl Med; 2019 Sep; 49(5):357-368. PubMed ID: 31470931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.